Register      Login
Sexual Health Sexual Health Society
Publishing on sexual health from the widest perspective
RESEARCH ARTICLE

Chlamydia testing and retesting patterns at family planning clinics in Australia

Anna L. Bowring A M , Jane L. Goller A , Maelenn Gouillou A , Caroline Harvey B , Deborah Bateson C , Kathleen McNamee D E , Christine Read F , Douglas Boyle G , Lynne Jordan D , Robyn Wardle H , Anne Stephens I , Basil Donovan J , Rebecca Guy J , Margaret Hellard A K L and on behalf of the ACCESS collaboration
+ Author Affiliations
- Author Affiliations

A Centre for Population Health, Burnet Institute, Melbourne, Vic. 3004, Australia.

B Family Planning Queensland, Brisbane, Qld 4006, Australia.

C Family Planning New South Wales, Sydney, NSW 2131, Australia.

D Family Planning Victoria, Melbourne, Vic. 3128, Australia.

E Department of Obstetrics and Gynaecology, Monash University, Melbourne, Vic. 3168, Australia.

F Lismore Family Planning, Lismore, NSW 2480, Australia.

G Rural Health Academic Centre, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Shepparton, Vic. 3630, Australia.

H Family Planning Welfare Association, Darwin, NT 810, Australia.

I Sexual Health Information Networking and Education South Australia, Adelaide, SA, 5011, Australia.

J Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia.

K Department of Epidemiology and Preventative Medicine, Monash University, Melbourne, Vic. 3004, Australia.

L Nossal Institute for Global Health, University of Melbourne, Melbourne, Vic. 3010, Australia.

M Corresponding author. Email: annab@burnet.edu.au

Sexual Health 10(1) 74-81 https://doi.org/10.1071/SH11187
Submitted: 22 December 2011  Accepted: 11 September 2012   Published: 21 December 2012

Abstract

Introduction: National guidelines recommend opportunistic chlamydia screening of sexually active 16- to 29-year-olds and encourage retesting 3–12 months after a diagnosed chlamydia (Chlamydia trachomatis) infection. We assessed chlamydia testing patterns at five Australian family planning clinics (FPCs). Methods: Using routine clinic data from 16- to 29-year-olds, we calculated chlamydia testing and positivity rates in 2008–2009. Reattendance, retesting and positivity rates at retesting within 1.5–4 and 1.5–12 months of a positive result were calculated. Results: Over 2 years, 13 690 individuals aged 16–29 years attended five FPCs (93% female). In 2008, 3159 females (41.4%,) and 263 males (57.0%) were tested for chlamydia; positivity was 8% and 19%, respectively. In 2009, 3178 females (39.6%) and 295 males (57.2%) were tested; positivity was 8% and 23%, respectively. Of 7637 females attending in 2008, 38% also attended in 2009, of which 20% were tested both years. Within 1.5–4 months of a positive test, 83 (31.1%) females reattended; the retesting rate was 13% and 12% retested positive. Within 1.5–12 months of a positive test, 96 (57.5%) females reattended; the retesting rate was 36% and 13% retested positive. Conclusions: Approximately 40% of young people attending FPCs were tested for chlamydia but a smaller proportion were tested annually or were retested following chlamydia infection. High positivity rates emphasise that FPCs see a high-risk population. To maximise testing opportunities, clinical prompts, patient reminder systems and non-clinic testing strategies may be needed.

Additional keywords: C. trachomatis, positivity, screening, young people.


References

[1]  Department of Health and Ageing (DoHA). Number of notifications of chlamydial infections, Australia, 2010 by age group and sex. National Notifiable Diseases Surveillance System. Canberra: DoHA; 2011.

[2]  Chen MY, Donovan B. Genital Chlamydia trachomatis infection in Australia: epidemiology and clinical implications. Sex Health 2004; 1 189–96.
Genital Chlamydia trachomatis infection in Australia: epidemiology and clinical implications.Crossref | GoogleScholarGoogle Scholar |

[3]  Department of Health and Ageing (DoHA). Number of notifications of chlamydial infections, Australia, 2009 by age group and sex. National Notifiable Diseases Surveillance System. Canberra: DoHA; 2010.

[4]  Hocking JS, Willis J, Tabrizi S, Fairley CK, Garland SM, Hellard M, et al A chlamydia prevalence survey of young women living in Melbourne, Victoria. Sex Health 2006; 3 235–40.
A chlamydia prevalence survey of young women living in Melbourne, Victoria.Crossref | GoogleScholarGoogle Scholar |

[5]  Bateson DJ, Weisberg E, Lota H, Bateson DJ, Weisberg E, Lota H. Chlamydia trachomatis infection in the family planning clinical setting across New South Wales. Sex Health 2006; 3 15–20.
Chlamydia trachomatis infection in the family planning clinical setting across New South Wales.Crossref | GoogleScholarGoogle Scholar |

[6]  Kong F, Hocking J, Link C, Chen M, Hellard M. Sex and sport: chlamydia screening in rural sporting clubs. BMC Infect Dis 2009; 9 73
Sex and sport: chlamydia screening in rural sporting clubs.Crossref | GoogleScholarGoogle Scholar |

[7]  Walker J, Tabrizi SN, Fairley CK, Chen MY, Bradshaw CS, Twin J, et al Chlamydia trachomatis incidence and re-infection among young women – behavioural and microbiological characteristics. PLoS ONE 2012; 7 e37778
Chlamydia trachomatis incidence and re-infection among young women – behavioural and microbiological characteristics.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC38XotF2htbg%3D&md5=4385cfdb35c3d41b4cf5d9441b985c5dCAS |

[8]  Peipert JF. Genital chlamydial infections. N Engl J Med 2003; 349 2424–30.
Genital chlamydial infections.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD3sXpvFGqur0%3D&md5=e1f9ad1432201e83c0b9014cb4ad7331CAS |

[9]  Nelson HD, Helfand M. Screening for chlamydial infection. Am J Prev Med 2001; 20 95–107.
Screening for chlamydial infection.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD38%2FgvVaisw%3D%3D&md5=4ff6f2e204d55497e024537889d69295CAS |

[10]  Regan DG, Wilson DP, Hocking JS. Coverage is the key for effective screening of Chlamydia trachomatis in Australia. J Infect Dis 2008; 198 349–58.
Coverage is the key for effective screening of Chlamydia trachomatis in Australia.Crossref | GoogleScholarGoogle Scholar |

[11]  Watson EJ, Templeton A, Russell I, Paavonen J, Mardh PA, Stary A, et al The accuracy and efficacy of screening tests for Chlamydia trachomatis: a systematic review. J Med Microbiol 2002; 51 1021–31.

[12]  Bourke S. National management guidelines for sexually transmissible infections, 7th ed. Melbourne: Sexual Health Society Of Victoria; 2008.

[13]  Harris MBJ, Del Mar C, Fasher M, Foreman L, Furler J, et al. Guidelines for preventive activities in general practice (the ‘red book’) 7th ed. Melbourne: The Royal Australian College of General Practitioners; 2009.

[14]  Australasian Society for HIV Medicine (ASHM). Australasian Contact Tracing Manual, 4th ed. Darlinghurst: ASHM; 2010. Available online at: http://ctm.ashm.org.au [verified May 2012].

[15]  Fung M, Scott KC, Kent CK, Klausner JD. Chlamydial and gonococcal reinfection among men: a systematic review of data to evaluate the need for retesting. Sex Transm Infect 2007; 83 304–9.
Chlamydial and gonococcal reinfection among men: a systematic review of data to evaluate the need for retesting.Crossref | GoogleScholarGoogle Scholar |

[16]  Hosenfeld CB, Workowski KA, Berman S, Zaidi A, Dyson J, Mosure D, et al Repeat infection with chlamydia and gonorrhea among females: a systematic review of the literature. Sex Transm Dis 2009; 36 478–89.
Repeat infection with chlamydia and gonorrhea among females: a systematic review of the literature.Crossref | GoogleScholarGoogle Scholar |

[17]  Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB. Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis 2010; 201 S134–55.
Risk of sequelae after Chlamydia trachomatis genital infection in women.Crossref | GoogleScholarGoogle Scholar |

[18]  Hillis SD, Owens LM, Marchbanks PA, Amsterdam LF, Mac Kenzie WR. Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. Am J Obstet Gynecol 1997; 176 103–7.
Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK2s7ns1Gmuw%3D%3D&md5=b22493cb7c724b4508110fc8ab601182CAS |

[19]  Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006. MMWR 2006; 55

[20]  Workowski KA, Lampe MF, Wong KG, Watts MB, Stamm WE. Long-term eradication of Chlamydia trachomatis genital infection after antimicrobial therapy. JAMA 1993 November 3; 270 2071–5.
Long-term eradication of Chlamydia trachomatis genital infection after antimicrobial therapy.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK2c%2FhslWjsA%3D%3D&md5=d992dc6a65caee9d6a3b6fed1d3e9648CAS |

[21]  Guy R, Kong F, Goller J, Franklin N, Bergeri I, Dimech W, et al A new national chlamydia surveillance system in Australia: evaluation of the first stage implementation. Commun Dis Intell 2010; 34 319–28.

[22]  Australian Bureau of Statistics (ABS). Australian standard geographical classification remoteness areas. Canberra: ABS; 2006.

[23]  Boyle D, Kong F. A systematic mechanism for the collection and interpretation of display format pathology test results from Australian primary care records. eJHI 2011; 6 e18

[24]  Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia. Annual surveillance report 2010. Sydney: Kirby Institute, The University of New South Wales; 2010.

[25]  Kong F, Guy R, Hocking J, Merritt T, Pirotta M, Heal C, et al Australian general practitioner chlamydia testing rates among young people. Med J Aust 2011; 195 249–52.

[26]  Merritt TD, Durrheim DN, Hope K, Byron P, Merritt TD, Durrheim DN, et al General practice intervention to increase opportunistic screening for chlamydia. Sex Health 2007; 4 249–51.
General practice intervention to increase opportunistic screening for chlamydia.Crossref | GoogleScholarGoogle Scholar |

[27]  Australasian Chapter of Sexual Health Medicine (ACSHM). Clinical guidelines for the management of sexually transmitted infections among priority populations. Sydney: The Royal Australasian College of Physicians, ACSHM; 2004.

[28]  Williams H, Tabrizi SN, Lee W, Kovacs GT, Garland S. Adolescence and other risk factors for Chlamydia trachomatis genitourinary infection in women in Melbourne, Australia. Sex Transm Infect 2003; 79 31–4.
Adolescence and other risk factors for Chlamydia trachomatis genitourinary infection in women in Melbourne, Australia.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3s%2Fms12hug%3D%3D&md5=1aff80781621215a46f3023830fe61ddCAS |

[29]  Han Y, Coles FB, Hipp S. Screening criteria for Chlamydia trachomatis in family planning clinics: accounting for prevalence and clients’ characteristics. Fam Plann Perspect 1997; 29 163–6.
Screening criteria for Chlamydia trachomatis in family planning clinics: accounting for prevalence and clients’ characteristics.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK2svgtlakug%3D%3D&md5=d730be46305d21bdb55e4d60632972b7CAS |

[30]  Burstein GR, Gaydos CA, Diener-West M, Howell MR, Zenilman JM, Quinn TC. Incident Chlamydia trachomatis infections among inner-city adolescent females. JAMA 1998; 280 521–6.
Incident Chlamydia trachomatis infections among inner-city adolescent females.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK1czntVKgug%3D%3D&md5=4962ad3fef933065d107864f5f33f346CAS |

[31]  Marrazzo J, Celum C, Hillis S, Fine D, DeLisle S, Handsfield H. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women: implications for a national chlamydia control strategy. Sex Transm Dis 1997; 24 131–41.
Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women: implications for a national chlamydia control strategy.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK2s3islGmtg%3D%3D&md5=8bde9f32beb6f8b970448f67c1214c32CAS |

[32]  Batteiger BE, Tu W, Ofner S, Van Der Pol B, Stothard DR, Orr DP, et al Repeated Chlamydia trachomatis genital infections in adolescent women. J Infect Dis 2010; 201 42–51.
Repeated Chlamydia trachomatis genital infections in adolescent women.Crossref | GoogleScholarGoogle Scholar |

[33]  Park IU, Amey A, Creegan L, Barandas A, Bauer HM. Retesting for repeat chlamydial infection: family planning provider knowledge, attitudes, and practices. J Womens Health (Larchmt) 2010; 19 1139–44.
Retesting for repeat chlamydial infection: family planning provider knowledge, attitudes, and practices.Crossref | GoogleScholarGoogle Scholar |

[34]  Fiks AG, Grundmeier RW, Biggs LM, Localio AR, Alessandrini EA. Impact of clinical alerts within an electronic health record on routine childhood immunization in an urban pediatric population. Pediatrics 2007 October 2007; 120 707–14.
Impact of clinical alerts within an electronic health record on routine childhood immunization in an urban pediatric population.Crossref | GoogleScholarGoogle Scholar |

[35]  Walker J, Fairley CK, Walker SM, Gurrin LC, Gunn JM, Pirotta MV, et al Computer reminders for chlamydia screening in general practice: a randomized controlled trial. Sex Transm Dis 2010; 37 445–50.
Computer reminders for chlamydia screening in general practice: a randomized controlled trial.Crossref | GoogleScholarGoogle Scholar |

[36]  Leong KC, Chen WS, Leong KW, Mastura I, Mimi O, Sheikh MA, et al The use of text messaging to improve attendance in primary care: a randomized controlled trial. Fam Pract 2006; 23 699–705.
The use of text messaging to improve attendance in primary care: a randomized controlled trial.Crossref | GoogleScholarGoogle Scholar |

[37]  Malotte CK, Ledsky R, Hogben M, Larro M, Middlestadt S, St Lawrence JS, et al Comparison of methods to increase repeat testing in persons treated for gonorrhea and/or chlamydia at public sexually transmitted disease clinics. Sex Transm Dis 2004; 31 637–42.
Comparison of methods to increase repeat testing in persons treated for gonorrhea and/or chlamydia at public sexually transmitted disease clinics.Crossref | GoogleScholarGoogle Scholar |

[38]  Cameron S, Glasier A, Scott G, Young H, Melvin L, Johnstone A, et al Novel interventions to reduce re-infection in women with chlamydia: a randomized controlled trial. Hum Reprod 2009; 24 888–95.
Novel interventions to reduce re-infection in women with chlamydia: a randomized controlled trial.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD1M3htlylsg%3D%3D&md5=6ae4c462c29b806dac7a4edb7fe77031CAS |

[39]  Cook RL, Østergaard L, Hillier SL, Murray PJ, Chang C-CH, Comer DM, et al Home screening for sexually transmitted diseases in high-risk young women: randomised controlled trial. Sex Transm Infect 2007; 83 286–91.
Home screening for sexually transmitted diseases in high-risk young women: randomised controlled trial.Crossref | GoogleScholarGoogle Scholar |

[40]  Xu F, Stoner BP, Taylor SN, Mena L, Tian LH, Papp J, et al Use of home-obtained vaginal swabs to facilitate rescreening for Chlamydia trachomatis infections: two randomized controlled trials. Obstet Gynecol 2011; 118 231–9.
Use of home-obtained vaginal swabs to facilitate rescreening for Chlamydia trachomatis infections: two randomized controlled trials.Crossref | GoogleScholarGoogle Scholar |